Our Commitment
At Sepax, we create value through serving customers’ needs and solving their chromatographic separation and purification challenges. Through innovative technologies and solution-based approaches, Sepax delivers products and services that build lasting relationships with customers, achieving a strong leadership role in the industry. At Sepax, we firmly believe that there is nothing too complicated or challenging for us to consider.
-
Annual Manufacturing Capacity
200,000 L
-
Global Locations
3
-
Global Customers
5,000 +
-
Patents
70 +
-
Innovative Technology
Superior
-
Publication Reference
1500 +
Sepax Technologies, Inc.
Sepax Technologies, Inc. is a Delaware, USA based leading chromatography product manufacturer and service provider specializing in biological separation areas. We offer unique ranges of HPLC columns for bioanalytical characterization and testing, as well as process media for downstream process and purification of MAb, BsMAb, ADC, Proteins, AAV, VLP, DNA, RNA, and various biologic samples. Sepax has a full portfolio of bead technology platforms, linker and organic synthesis chemistry, as well as protein chemistry in different stages of R&D and production pipelines to support the various needs of the biopharmaceutical industry and our customers. Certified to ISO 9001:2015 standards, Sepax focuses on customer & market needs, and is continuing to expand its presence and supply chain around the globe.
-
2002
Sepax Technologies, Inc. was founded in Delaware, USA.
-
2005
Launched analytical chromatography columns in the European and North American markets.
-
2009
Suzhou Sepax Technologies Co., Ltd. was founded in Suzhou, China.
-
2012
Expanded into industrial-scale purification with specialized chromatography resins.
-
2015
Achieved commercial-scale production of insulin-specific chromatography resins.
-
2017
Yangzhou Sepax Technologies Co., Ltd. was founded in Yangzhou, China.
-
2018
Completed a 280,000 sq. ft. R&D and office facility in Suzhou.
-
2021
Phase I of Sepax Yangzhou was completed, featuring eight product lines, including media specialized for antibody purification.
-
2022
Sepax Bioscience Inc. was founded in Delaware, USA, forming a global platform integrating resin development, manufacturing, and sales.
-
2025
Listed on the Shanghai Stock Exchange STAR Market (688758.SH), marking a new chapter as a publicly traded company.
Quality Control
Certified to ISO 9001:2015 standards, Sepax is committed to delivering consistent product quality and superior performance across its entire portfolio. Our quality management system is designed to ensure traceability, reproducibility, and compliance at every stage of manufacturing and development. Sepax’s commitment to quality extends beyond compliance—we proactively engage with customers to understand evolving application needs, enabling continuous improvement and innovation. As we expand our global footprint and strengthen our supply chain capabilities, quality remains at the heart of everything we do—ensuring reliable results and customer satisfaction worldwide.
-
USA Sepax 2013.8
ISO 9001:2015